Baseline demographic and clinical characteristics, including age, sex, BMI, tumor stage, surgical approach, preoperative psychosocial and nutritional scores (CD-RISC, HADS, PSQI, albumin, BMI), as well as treatment-related variables such as neoadjuvant chemoradiation (62% overall; 61.8% in the intervention group vs. 61.8% in the control group, P = 1.000) and protective diverting stoma creation (71.9% vs. 69.7%, P = .763), were comparable between the two groups (all P > .05; Table 1). Here, ALB is linked to neoplasm.